Colinz Laboratories Limited (BOM:531210)
82.94
+0.37 (0.45%)
At close: Jul 28, 2026
Colinz Laboratories Revenue
In the fiscal year ending March 31, 2026, Colinz Laboratories had annual revenue of 61.36M INR, down -6.00%. Colinz Laboratories had revenue of 17.48M in the quarter ending March 31, 2026, with 20.43% growth.
Revenue
61.36M
Revenue Growth
-6.00%
P/S Ratio
3.41
Revenue / Employee
944.02K
Employees
65
Market Cap
208.93M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 61.36M | -3.92M | -6.00% |
| Mar 31, 2025 | 65.28M | -5.02M | -7.14% |
| Mar 31, 2024 | 70.30M | -1.25M | -1.75% |
| Mar 31, 2023 | 71.55M | 1.81M | 2.59% |
| Mar 31, 2022 | 69.74M | 8.15M | 13.24% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Welcure Drugs and Pharmaceuticals | 3.66B |
| Add-Shop E-Retail | 1.55B |
| Deccan Health Care | 819.05M |
| Panjon | 476.21M |
| Gujarat Terce Laboratories | 474.73M |
| Cian Healthcare | 232.80M |
| Zenith Healthcare | 105.22M |
| Hamps Bio | 84.75M |